Reflect Scientific Inc. Secures $225,000 Order for Cutting-Edge Freezer Systems
Reflect Scientific Inc. (OTCQB: RSCF) has secured a $225,000 order for its advanced blast freezing systems from a major Asia-based BioPharma company. This marks the eighth follow-on order from this client, indicating full adoption and standardization of Reflect Scientific's freezing technology. The order demonstrates the company's strong position in the global biotech market and the reliability of its products.
CEO Kim Boyce highlighted that this repeat order validates the superior performance and cost-effectiveness of their freezer systems. The sales from this order will be reflected in Reflect Scientific's third quarter 2024 financial results. This development signals positive momentum for the company as it expands its market presence and strengthens relationships with key industry players in the pharmaceutical and biotechnology sectors.
Reflect Scientific Inc. (OTCQB: RSCF) ha ricevuto un ordine di $225.000 per i suoi avanzati sistemi di congelamento rapido da una importante azienda BioPharma con sede in Asia. Questo rappresenta il l'ottavo ordine consecutivo da questo cliente, indicando un'adozione e una standardizzazione complete della tecnologia di congelamento di Reflect Scientific. L'ordine dimostra la forte posizione dell'azienda nel mercato biotech globale e l'affidabilità dei suoi prodotti.
Il CEO Kim Boyce ha evidenziato che questo ordine ripetuto convalida le prestazioni superiori e il rapporto costo-efficacia dei loro sistemi di congelamento. Le vendite di questo ordine saranno riflesse nei risultati finanziari del terzo trimestre 2024 di Reflect Scientific. Questo sviluppo segnala un momento positivo per l'azienda mentre espande la sua presenza sul mercato e rafforza le relazioni con i principali attori del settore farmaceutico e biotecnologico.
Reflect Scientific Inc. (OTCQB: RSCF) ha asegurado un pedido de $225,000 para sus avanzados sistemas de congelación rápida de una importante empresa BioPharma con sede en Asia. Este es el octavo pedido consecutivo de este cliente, lo que indica una completa adopción y estandarización de la tecnología de congelación de Reflect Scientific. El pedido demuestra la sólida posición de la empresa en el mercado biotecnológico global y la fiabilidad de sus productos.
El CEO Kim Boyce destacó que este pedido repetido valida el rendimiento superior y la rentabilidad de sus sistemas de congelación. Las ventas de este pedido se reflejarán en los resultados financieros del tercer trimestre de 2024 de Reflect Scientific. Este desarrollo señala un impulso positivo para la empresa a medida que expande su presencia en el mercado y fortalece las relaciones con los actores clave en los sectores farmacéutico y biotecnológico.
Reflect Scientific Inc. (OTCQB: RSCF)는 아시아에 본사를 둔 주요 BioPharma 회사로부터 $225,000의 주문을 확보했습니다. 이는 고객으로부터 여덟 번째 후속 주문으로, Reflect Scientific의 냉동 기술이 완전히 채택되고 표준화되었음을 나타냅니다. 이 주문은 회사가 글로벌 생명공학 시장에서 강력한 위치를 차지하고 있으며 제품의 신뢰성을 보여줍니다.
CEO Kim Boyce는 이 반복 주문이 그들의 냉동 시스템의 우수한 성능과 비용 효율성을 검증한다고 강조했습니다. 이 주문의 판매는 Reflect Scientific의 2024년 3분기 재무 결과에 반영될 것입니다. 이 발전은 회사가 시장 점유율을 확장하고 제약 및 생명공학 분야의 주요 산업 관계를 강화함에 따라 긍정적인 모멘텀을 나타냅니다.
Reflect Scientific Inc. (OTCQB: RSCF) a obtenu une commande de 225 000 $ pour ses systèmes avancés de congélation rapide d'une grande entreprise BioPharma basée en Asie. Cela marque la huitième commande consécutive de ce client, indiquant une adoption et une standardisation complète de la technologie de congélation de Reflect Scientific. Cette commande démontre la position solide de l'entreprise sur le marché biotechnologique mondial et la fiabilité de ses produits.
Le PDG Kim Boyce a souligné que cette commande répétée valide la performance supérieure et le rapport coût-efficacité de leurs systèmes de congélation. Les ventes provenant de cette commande seront reflétées dans les résultats financiers du troisième trimestre 2024 de Reflect Scientific. Ce développement signale un élan positif pour l'entreprise alors qu'elle étend sa présence sur le marché et renforce ses relations avec les acteurs clés des secteurs pharmaceutique et biotechnologique.
Reflect Scientific Inc. (OTCQB: RSCF) hat einen Auftrag über $225.000 für seine fortschrittlichen Schnellgefrieren-Systeme von einem großen in Asien ansässigen BioPharma-Unternehmen gesichert. Dies ist der achte Folgeauftrag dieses Kunden, was auf die vollständige Übernahme und Standardisierung der Gefriertechnologie von Reflect Scientific hindeutet. Der Auftrag zeigt die starke Position des Unternehmens auf dem globalen Biotech-Markt und die Zuverlässigkeit seiner Produkte.
CEO Kim Boyce betonte, dass dieser Wiederholungsauftrag die überlegene Leistung und Kosteneffektivität ihrer Gefriersysteme validiert. Die Verkäufe aus diesem Auftrag werden in den Finanzergebnissen des dritten Quartals 2024 von Reflect Scientific dargestellt. Diese Entwicklung signalisiert einen positiven Schwung für das Unternehmen, während es seine Marktpräsenz ausbaut und Beziehungen zu wichtigen Akteuren in den Pharma- und Biotechnologiesektoren stärkt.
- Secured a $225,000 order for blast freezing systems
- Eighth follow-on order from the same customer, indicating strong product adoption
- Sales to be reflected in Q3 2024 financial results
- Demonstrates strong position in global biotech market
- Signals expansion of market presence and strengthening of key industry relationships
- None.
OREM, Utah, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Reflect Scientific Inc. (OTCQB: RSCF), a leading innovator in cryogenic technology, announced today that it has received a
This order marks the eighth follow-on order from this client, demonstrating their full adoption and standardization of Reflect Scientific's advanced freezing technology. The continued partnership underscores the Company's strong position in the global biotech market and the reliability of its products.
"This repeat order validates the superior performance and cost-effectiveness of our freezer systems," said Kim Boyce, CEO of Reflect Scientific. "Our technology continues to meet the demanding requirements of the biopharmaceutical industry, positioning us for sustained growth."
Reflect Scientific's third quarter 2024 financial results will reflect the sales from this order. This development signals positive momentum for the Company as it continues to expand its market presence and strengthen relationships with key industry players.
Investors are encouraged to follow Reflect Scientific's progress as it capitalizes on the growing demand for advanced cryogenic solutions in the global pharmaceutical and biotechnology sectors.
About Reflect Scientific, Inc.
Reflect Scientific, Inc., based in Orem, Utah, develops and markets innovative, proprietary technologies in cryogenic cooling for the biotechnology, pharmaceutical, medical, and transportation markets. Among Reflect Scientific's products are low-temperature freezers and refrigerated systems for laboratory, transportation, and computer server room uses. Visit reflectscientific.com for more information. See us on Twitter @ReflectSci and LinkedIn www.linkedin.com/company/reflect-scientific.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are not a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainties and other factors that may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this press release. This press release should be considered in light of the disclosures contained in the filings of the Company that are contained in the OTC Markets Group, LLC under the trading symbol "RSCF" and related prior filings by the Company that are referenced therein and contained in the EDGAR Archives of the Securities and Exchange Commission under the heading "Disclosure," including those identified in such filings as "forward-looking statements."
FAQ
What is the value of the new order received by Reflect Scientific (RSCF)?
How many follow-on orders has this customer placed with Reflect Scientific (RSCF)?
When will the sales from this order be reflected in Reflect Scientific's (RSCF) financial results?
What markets does Reflect Scientific (RSCF) serve with its cryogenic cooling technologies?
